Dr. James Creeden has been Chief Medical Officer for Roche Professional Diagnostics, the world's leading In Vitro Diagnostics manufacturer, since 2008. As Chief Medical Officer for Professional Diagnostics, his department is responsible for medical strategy and clinical development for their diagnostics solutions and companion diagnostic products. His current focus is transforming the IVD industry’s leading diagnostics technology company into the world’s leading diagnostics healthcare company through the generation of compelling clinical utility evidence. Dr. Creeden holds a PhD in molecular toxicology from Rutgers University and an MD from Robert Wood Johnson Medical School. After training in general medicine, Dr. Creeden left clinical practice in 2002 to join Roche Pharmaceuticals Genetics and Integrated Medicines, where he worked on viral and host polymorphisms linked to response to antiretrovirals. He came to Basel in 2004 to work in epidemiology and health economics of personalized medicines, and joined the Diagnostics division in 2007.